Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine with Radiotherapy in Elderly High Grade Glioma
NCT01602588Phase 2Completed
- Sponsor
- University College London
- Start
- May 2013
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of hydroxychloroquine in high-grade glioma (HGG) (2 arms), sponsored by University College London. Primary endpoint: 1 year Survival. Started May 2013; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT01602588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01602588.